Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 54,294	$ 38,871	$ 106,999	$ 74,909
General and administrative	10,093	8,214	19,792	15,413
Total operating expenses	64,387	47,085	126,791	90,322
Loss from operations	(64,387)	(47,085)	(126,791)	(90,322)
Other income:
Interest income	5,393	2,741	9,450	5,009
Other income, net	44	268	43	950
Change in fair value of CVR liability	0	0	0	1,700
Total other income, net	5,437	3,009	9,493	7,659
Net loss	$ (58,950)	$ (44,076)	$ (117,298)	$ (82,663)
Net loss per share attributable to common stockholders, basic	$ (0.59)	$ (0.59)	$ (1.21)	$ (1.14)
Net loss per share attributable to common stockholders, diluted	$ (0.59)	$ (0.59)	$ (1.21)	$ (1.14)
Weighted average common shares outstanding, basic	99,240,030	74,753,269	97,022,345	72,755,210
Weighted average common shares outstanding, diluted	99,240,030	74,753,269	97,022,345	72,755,210
Comprehensive loss:
Net loss	$ (58,950)	$ (44,076)	$ (117,298)	$ (82,663)
Other comprehensive loss
Net unrealized gains (losses) on marketable securities	(153)	(113)	(438)	7
Total other comprehensive loss	(153)	(113)	(438)	7
Comprehensive loss	$ (59,103)	$ (44,189)	$ (117,736)	$ (82,656)